Also, it might look a little fishy if the CEO starts buying shares when his own company stock is right at an all time low. If Nader was in this for the paycheck only i don't thing he would be pushing the trial process as much as they are. He would be sewing a story of how these things take time etc.. He, the board and Micheal Know the goal is a buyout/partnership. I feel that there are milestones that must be met before serious talks happen, an agreed on FDA protocal is one of them. No big pharma knowingly spends billions on a treatment that may not work or has a history of failed FDA trials/protocals.
News 
Market Data 
Discover 
AI
